drugset / Trial / NCT03070509
Pharmacokinetics of Lisdexamfetamine (Vyvanse®) in Post-bariatric Surgery Patients
Phase 4
Unknown
20 enrolled
North Dakota State University
Neuropsychiatric Research Institute, Fargo, North Dakota · collabShire · collab
Non-randomizedParallel-groupOpen-labelOther
Summary
This study is being conducted to evaluate how the body absorbs and processes the medication lisdexamfetamine (Vyvanse®). Subjects who are 9-15 months post gastric bypass surgery will be invited to participate. Non-surgical controls will also be enrolled based on a matching criteria to post gastric bypass subjects. Participants will be asked to complete one 12-hour study day and complete one 24-hour post dosing blood draw.
Timeline
- Start
- 2017-05-12
- Primary completion
- 2019-07
- Completion
- 2019-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lisdexamfetamine | Other / unclassified | 50 mg | — |
Indications
No indication recorded.